Published in Cardiovascular Business Week, March 3rd, 2009
"This is a very important clinical study comparing the WATCHMAN to warfarin in the management of patients with atrial fibrillation. We are looking...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.